Article info

Download PDFPDF

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

Authors

  1. Correspondence to Barnaby Hunt; hunt{at}ossianconsulting.com
View Full Text

Citation

Hunt B, Malkin SJP, Moes RGJ, et al
Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

Publication history

  • Received June 7, 2019
  • Revised August 29, 2019
  • Accepted September 11, 2019
  • First published October 1, 2019.
Online issue publication 
October 01, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.